Featured Research

from universities, journals, and other organizations

New Treatment For Chronic Arthritis-Related Back Pain

Date:
October 6, 2007
Source:
Mayo Clinic
Summary:
Radiofrequency ablation, where heat energy destroys or stuns the nerves of a painful joint, is a developing therapy for chronic arthritis-related back pain. In the right situation, this approach may be welcome -- though usually not permanent -- relief, according to the Mayo Clinic. The best candidates for this procedure are those who have arthritis that's primarily confined to the spinal area, and possibly the upper buttock region. In an outpatient procedure, doctors apply radiofrequency energy either continuously for one to two minutes to destroy the pain-causing nerve tissue; or in pulses to stun the nerves.

Radiofrequency ablation, where heat energy destroys or stuns the nerves of a painful joint, is a developing therapy for chronic arthritis-related back pain. In the right situation, this approach may be welcome -- though usually not permanent -- relief, according to the October issue of Mayo Clinic Health Letter.

Related Articles


The best candidates for this procedure are those who have arthritis that’s primarily confined to the spinal area, and possibly the upper buttock region. In an outpatient procedure, doctors apply radiofrequency energy either continuously for one to two minutes to destroy the pain-causing nerve tissue; or in pulses to stun the nerves.

The majority of people who opt for continuous radiofrequency treatment experience a greater than 50 percent pain reduction. The relief lasts an average of six to nine months. It’s not clear why pain often returns, but doctors suspect that the nerves reconnect over time. The procedure can be repeated. However, patients may experience diminishing benefits with repeated treatments.

Pulsed radiofrequency may be as effective in pain relief as the continuous method, but the relief generally does not last as long. In theory, since the tissue is stunned and not destroyed, the pulsed treatment is safer and not expected to offer diminishing returns when repeated.

Definitive research has not accurately quantified success rates. But for patients with arthritis-related back pain that hasn’t responded to other treatments, radiofrequency ablation is an option.


Story Source:

The above story is based on materials provided by Mayo Clinic. Note: Materials may be edited for content and length.


Cite This Page:

Mayo Clinic. "New Treatment For Chronic Arthritis-Related Back Pain." ScienceDaily. ScienceDaily, 6 October 2007. <www.sciencedaily.com/releases/2007/10/071005153509.htm>.
Mayo Clinic. (2007, October 6). New Treatment For Chronic Arthritis-Related Back Pain. ScienceDaily. Retrieved March 6, 2015 from www.sciencedaily.com/releases/2007/10/071005153509.htm
Mayo Clinic. "New Treatment For Chronic Arthritis-Related Back Pain." ScienceDaily. www.sciencedaily.com/releases/2007/10/071005153509.htm (accessed March 6, 2015).

Share This


More From ScienceDaily



More Health & Medicine News

Friday, March 6, 2015

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Bupa Eyes India Healthcare Opportunities

Bupa Eyes India Healthcare Opportunities

Reuters - Business Video Online (Mar. 5, 2015) Bupa is hoping to expand in India&apos;s fast-growing health insurance market, once a rule change on foreign investment is implemented. The British private healthcare group&apos;s CEO tells Grace Pascoe why it&apos;s so keen on the new opportunity. Video provided by Reuters
Powered by NewsLook.com
Doctor in Your Pocket Is Getting Smarter

Doctor in Your Pocket Is Getting Smarter

Reuters - Business Video Online (Mar. 5, 2015) Mobile apps are turning smartphones into a personal doctors, with users able to measure heart rate, blood pressure and even blood sugar. But will it change our behaviour? Ivor Bennett reports from the Mobile World Congress in Barcelona. Video provided by Reuters
Powered by NewsLook.com
AbbVie Inks $21B Deal To Buy Cancer Drugmaker Pharmacyclics

AbbVie Inks $21B Deal To Buy Cancer Drugmaker Pharmacyclics

Newsy (Mar. 5, 2015) AbbVie announced Wednesday it will buy cancer drugmaker Pharmacyclics in a $21 billion deal. Video provided by Newsy
Powered by NewsLook.com
Toddlers Drinking Coffee? Why You Shouldn't Share Your Joe

Toddlers Drinking Coffee? Why You Shouldn't Share Your Joe

Newsy (Mar. 5, 2015) A survey of Boston mothers and toddlers found that 15 percent of two-year-olds drink coffee and 2.5 percent of 1-year-olds. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins